Management and outcome of high-risk peritonitis: A retrospective survey 2005-2009

International Journal of Infectious Diseases

Volumn 15, Issue 11, 2011, Pages

  Theunissen, Caroline ^a   Cherifi, Soraya ^a   Karmali, Rafik ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Etiology; High risk peritonitis; Outcome

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COMMUNICABLE DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE TRANSMISSION; ENTEROCOCCAL INFECTION; FEMALE; HEALTH SURVEY; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PATIENT SELECTION; PERITONITIS; PRACTICE GUIDELINE; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; BELGIUM; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE MANAGEMENT; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; GUIDELINES AS TOPIC; HOSPITALS, UNIVERSITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PERITONITIS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80054887586     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.06.008     Document Type: Article

References (20)

1. Solomkin J.S., Mazuski J.E., Baron E.J., Sawyer R.G., Nathens A.B., DiPiro J.T., et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003, 37:997-1005.
2. Cristou N.V., Barie P.S., Dellinger E.P., Waymack J.P., Stone H.H. Surgical Infection Society Intra-abdominal Infection Study. Prospective evaluation of management techniques and outcome. Arch Surg 1993, 128:193-199.
3. Blot S., De Waele J.J. Critical issues in the clinical management of complicated intra-abdominal infections. Drugs 2005, 65:1611-1620.
4. Dougherty S.H., Saltzein E.C., Peacock J.B., Mercer L.C., Cano P. Perforated or gangrenous appendicitis treated with aminoglycosides: how do bacterial cultures influence management. Arch Surg 1989, 124:1280-1283.
5. Montravers P., Chalfine A., Gauzir R., Lepape A., Pierre Marmuse J., Vouillot C., et al. Clinical and therapeutic features of nonpostoperative nosocomial intra-abdominal infections. Ann Surg 2004, 239:409-416.
6. Solomkin J.S., Mazuski J.E., Bradley J.S., Rodvold K.A., Goldstein E.J.C., Baron E.J., et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010, 50:133-164.
7. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987, 40:373-383.
8. Charlson M., Szatrowski T.P., Peterson J., Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994, 47:1245-1251.
9. Linder M., Wacha H., Feldmann U., Wesch G., Streifensand F.A., Gundlach E. The Mannheim peritonitis index. An instrument for the intraoperative prognosis of peritonitis. Chirurg 1987, 58:84-92.
10. Notash A.Y., Salimi J., Rahimian H., Fesharaki M.H., Abbasi A. Evaluation of Mannheim peritonitis index and multiple organ failure score in patients with peritonitis. Indian J Gastroenterol 2005, 24:197-200.
11. Roehrborn A., Thomas L., Potreck O., Ebener C., Ohmann C., Goretzki P.E., et al. The microbiology of postoperative peritonitis. Clin Infect Dis 2001, 33:1213-1219.
12. Klevens R.M., Morrison M.A., Nadel J., Petit S., Gershman K., Ray S., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
13. Mosdell D.M., Morris D.M., Volture A., Pitcher D.A., Twiest M.W., Milne R.L., et al. Antibiotic treatment for surgical peritonitis. Ann Surg 1991, 214:543-549.
14. Montravers P., Gauzit R., Muller C., Marmuse J.P., Fichelle A., Desmonts J.M. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996, 23:486-494.
15. Falagas M.E., Barefoot L., Griffith J., Ruthazar R., Snydman D.R. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections. Eur J Clin Microbiol Infect Dis 1996, 15:913-921.
16. De Waele J.J., Hoste E.A., Blot S. Blood stream infections of abdominal origin in the intensive care unit: characteristics and determinants of death. Surg Infect (Larchmt) 2008, 9:171-177.
17. Schoeffel U., Jacobs E., Ruf G., Mierswa F., von Specht B.U., Farthmann E.H. Intraperitoneal micro-organisms and the severity of peritonitis. Eur J Surg 1995, 161:501-508.
18. Sotto A., Lefrant J.Y., Fabbro-Peray P., Muller L., Tafuri J., Navarro F., et al. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother 2002, 50:539-576.
19. Dunn D.L., Barke R.A., Knight N.B., Humphrey E.W., Simmons R.L. The role of resident macrophages, peripheral neutrophils, and translymphatic absorption in bacterial clearance from the peritoneal cavity. Infect Immun 1985, 49:257-264.
20. Dahms R.A., Johnson E.M., Statz C.L., Lee J.T., Dunn D.L., Beilman G.J. Third generation cephalosporins and vancomycin as a risk factor for postoperative vancomycin resistant Enterococcus infection. Arch Surg 1998, 133:1343-1346.